UK markets closed

Thermo Fisher Scientific Inc. (0R0H.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
541.35-8.88 (-1.61%)
At close: 07:10PM BST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.80
52-week change 36.63%
S&P500 52-week change 321.61%
52-week high 3603.14
52-week low 3416.65
50-day moving average 3556.84
200-day moving average 3522.32

Share statistics

Avg vol (3-month) 313.25k
Avg vol (10-day) 312.78k
Shares outstanding 5402.58M
Implied shares outstanding 6N/A
Float 8380.42M
% held by insiders 10.18%
% held by institutions 192.22%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 31.40
Trailing annual dividend yield 30.25%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 13.99%
Operating margin (ttm)18.66%

Management effectiveness

Return on assets (ttm)4.72%
Return on equity (ttm)13.09%

Income statement

Revenue (ttm)42.86B
Revenue per share (ttm)111.03
Quarterly revenue growth (yoy)-4.90%
Gross profit (ttm)N/A
EBITDA 10.8B
Net income avi to common (ttm)5.99B
Diluted EPS (ttm)19.19
Quarterly earnings growth (yoy)3.40%

Balance sheet

Total cash (mrq)8.08B
Total cash per share (mrq)21.18
Total debt (mrq)36.71B
Total debt/equity (mrq)78.37%
Current ratio (mrq)1.75
Book value per share (mrq)120.87

Cash flow statement

Operating cash flow (ttm)8.41B
Levered free cash flow (ttm)5.14B